{"id":4003,"date":"2017-10-26T09:15:29","date_gmt":"2017-10-26T13:15:29","guid":{"rendered":"http:\/\/nchstats.com\/?p=4003"},"modified":"2025-02-03T19:02:12","modified_gmt":"2025-02-03T19:02:12","slug":"total-and-high-density-lipoprotein-cholesterol-in-adults-united-states-2015-2016","status":"publish","type":"post","link":"https:\/\/blogs.cdc.gov\/nchs\/2017\/10\/26\/4003\/","title":{"rendered":"Total and High-density Lipoprotein Cholesterol in Adults: United States, 2015\u20132016"},"content":{"rendered":"

Questions for Margaret Carroll, M.S.P.H., Health Statistician and Lead Author on \u201cTotal and High-density Lipoprotein Cholesterol in Adults: United States, 2015\u20132016<\/a>\u201d<\/p>\n

Q<\/em><\/strong>:<\/strong> How has the prevalence of high total cholesterol and low levels of high-density lipoprotein (HDL) in U.S. changed since 1999-2000 to 2015-2016?<\/p>\n

MC<\/em><\/strong>:<\/strong> The prevalence of high total cholesterol (>=240 mg\/dL) of adults 20 years and older declined from 1999-2000 to 2015-2016; the prevalence of low high-density lipoprotein(HDL) cholesterol (<40 mg\/dL) declined\u00a0 in adults 20 years and older from 2007-2008 to 2015-2016.\u00a0 No change was seen from 2013-2014 to 2015-2016 in either high total cholesterol or low HDL cholesterol.<\/p>\n

\n

Q<\/em><\/strong>: <\/strong>Why is it important to study the prevalence of high total and low HDL cholesterol?<\/p>\n

MC: <\/em><\/strong>High levels of total cholesterol and low levels of HDL cholesterol are risk factors for cardiovascular disease, the leading cause of death in the United States.<\/p>\n

Also, as part of its objectives to improve the health of the U.S. population, Healthy People 2020 has included the goal of reducing the proportion of adults with high total blood cholesterol to less than 13.5%. Both men and women aged 20 and over currently meet this goal. However, not all subgroups meet this target.<\/p>\n

\n

Q: <\/em><\/strong>Was there anything in the report that surprised you?<\/p>\n

MC<\/em><\/strong>: The findings did not particularly surprise me.\u00a0 Based on the earliest available and comparable data from the National Health and Nutrition Examination Survey (NHANES), declining trends were observed in high total cholesterol from 1999\u20132000 to 2015\u20132016 and in low HDL cholesterol from 2007\u20132008 to 2015\u20132016. However, the observed change for high total and low HDL cholesterol from 2013\u20132014 to 2015\u20132016 was not statistically significant.<\/p>\n

\n

Q:<\/em><\/strong> How does the prevalence of high total and low HDL cholesterol breakdown by age and sex in U.S.?<\/p>\n

MC:<\/em><\/strong> Men ages 40-59 years have a higher prevalence of high total cholesterol than men ages 20-39 years and 60 years and older but there is no significant difference between men 20-39 years and those 60 years and older.\u00a0 The prevalence of high total cholesterol is lower in women ages 20-39 years than in women 40-59 years and 60 years and older but there is no significant difference between women 40-59 years and 60 years and older.<\/p>\n

Men ages 40-59 years have a higher prevalence of low HDL cholesterol than men 60 years and older.\u00a0 A declining trend in the prevalence of low HDL cholesterol was seen in women from 20-39 years and 60 years and older.<\/p>\n

\n

Q<\/em><\/strong>:<\/strong> What is the take-home message from this report?\u00a0<\/strong><\/p>\n

MC: <\/em><\/strong>High total cholesterol has declined in adults 20 years from 1999-2000 to 2015-2016 and low HDL cholesterol has declined from 2007-2008 to 2015-2016.<\/p>\n","protected":false},"excerpt":{"rendered":"

Questions for Margaret Carroll, M.S.P.H., Health Statistician and Lead Author on \u201cTotal and High-density Lipoprotein Cholesterol in Adults: United States, 2015\u20132016\u201d Q: How has the prevalence of high total cholesterol and low levels of high-density lipoprotein (HDL) in U.S. changed since 1999-2000 to 2015-2016? MC: The prevalence of high total cholesterol (>=240 mg\/dL) of adults<\/p>\n","protected":false},"author":195,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32978,50899],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/posts\/4003"}],"collection":[{"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/users\/195"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/comments?post=4003"}],"version-history":[{"count":1,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/posts\/4003\/revisions"}],"predecessor-version":[{"id":7731,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/posts\/4003\/revisions\/7731"}],"wp:attachment":[{"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/media?parent=4003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/categories?post=4003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cdc.gov\/nchs\/wp-json\/wp\/v2\/tags?post=4003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}